
Opinion: The science on relieving cancer symptoms is clear. Why isn’t insurance paying?
Research shows that integrative therapies reduce cancer-related pain, fatigue, anxiety, and nausea. Why won't insurance pay?
148 stories found

Research shows that integrative therapies reduce cancer-related pain, fatigue, anxiety, and nausea. Why won't insurance pay?

“Researchers must seize this opportunity to examine how social media — and its regulation — impacts teenagers,” writes Wellcome’s Camilla Iannone.

Why an influential GOP health policy expert still backs $1 trillion in Medicaid cuts — and which policy target is next.

The race between Amy Acton and Vivek Ramaswamy could be the election’s most direct test of where the heartland stands on health care and the pandemic.

Several members of Congress voiced strong opposition about a reported plan to create a panel of political appointees to sign off on NIH grants

The FDA just approved a new combination drug treatment for patients with an advanced form of breast cancer.

Novo Nodisk outlined plans to expand its pipeline and find new products that it could sell more like consumer goods than traditional medicines

A day after health secretary Robert F. Kennedy Jr. promised that parents concerned about vaccines had a “friend” in the White House, President Trump said he’ll be “demanding” that drug…

The drugmaker Alkermes said a therapy called an orexin agonist for the first time showed potential to treat people with ADHD in an early-stage study.

Under investor pressure, Novo presented its strategy to both grow its obesity franchise and diversify its pipeline.

It’s hard to identify which clinical trials pregnant and lactating patients can join. Here’s one fix, experts write.

Addiction clinics are seeing a surge in patients dependent on potent kratom and 7-OH products.

"I know what it means to be searching for an explanation to what ails you, and a way to fix it," writes STAT's new trust-in-science reporter, Nicholas Florko.
STAT's Alex Hogan sits down for an in-depth conversation with our new trust-in-science reporter, Nicholas Florko, on the latest episode of STATus Report.

How one state's governor's race is a test of whether Robert F. Kennedy Jr.'s MAHA movement has an enduring political draw.

“We should be strengthening our investment in the NIH, not dismantling it,” writes Reed Jobs.

ITM Isotope Technologies Munich SE and Telix Pharmaceuticals, two leading companies in the burgeoning radiopharmaceuticals field, are merging.

The Jehovah’s Witnesses have partly eased their longstanding prohibition on the medical use of donated blood.

Every state will participate in the GENEROUS program, but many of the details are unknown.

Several Texas hospitals are suing an out-of-state Blue Cross for unpaid medical claims, highlighting the varying standards for whether care is medically necessary.